The FDA today approved the Subcutaneous Implantable Defibrillator (S-ICD) system from Cameron Health. The device is the first ICD that does not require a lead that connects directly to the heart and ...
Please provide your email address to receive an email when new articles are posted on . Researchers have developed a risk model to help predict the chances of adverse events after a patient receives ...
NEW ORLEANS, Nov. 9 – A small study of patients with heart failure not caused by blocked arteries indicates that women, as well as men, may benefit from implantable cardioverter-defibrillators (ICD) ...
"Appropriately selected patients with NICM have the potential to benefit from primary prevention ICD therapy…Besides consideration of ICD placement, attention to guideline-directed medical therapy and ...
(HealthDay News) – A simple model may be used to predict risk for in-hospital adverse events among patients receiving an implantable cardioverter defibrillator (ICD), according to research published ...
Placement of an implantable cardioverter-defibrillator (ICD) in patients with non-ischemic systolic heart failure did not improve overall survival compared to usual clinical care -- although a ...
This study sought to explore patients' attitudes and perceptions of ICDs to better understand potential patient-related barriers to appropriate ICD utilization. Although many prior studies have ...
Study finds no difference in all-cause mortality among patients with chronic kidney disease and heart failure who received implantable cardioverter defibrillators and those who did not. Research has ...
A 51-year-old female with a medical history of nonischemic cardiomyopathy developed heart failure symptoms, left bundle branch block, and decreased ejection fraction, leading to the placement of an ...
Late-breaking data presented at ESC Congress 2022 and simultaneously published in The New England Journal of Medicine confirms implant procedure safety and defibrillation success DUBLIN and BARCELONA, ...